Similar articles

• [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].

  Scherübl H, Schaaf L, Raue F, Faiss S, Zeitz M. Scherübl H, et al. Dtsch Med Wochenschr. 2004 Mar 26;129(13):689-92. doi: 10.1055/s-2004-821371. Dtsch Med Wochenschr. 2004. PMID: 15026965 German. No abstract available.
• Medical treatment of endocrine gastroenteropancreatic tumors.

  Tomassetti P, Campana D, Nori F, Piscitelli L, Salomone L, Pezzilli R, Corinaldesi R. Tomassetti P, et al. JOP. 2006 Jan 11;7(1):145-9. JOP. 2006. PMID: 16407637 No abstract available.
• [Treatment of neuroendocrine tumours of the gastrointestinal tract].

  Hansen CP, Langer S, Frevert S, Mortensen J, Kjaer A, Knigge U. Hansen CP, et al. Ugeskr Laeger. 2010 Oct 25;172(43):2942-5. Ugeskr Laeger. 2010. PMID: 21040671 Danish.
• New directions in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): shifting from symptom management to targeting tumors.

  Weber M. Weber M. Clin Adv Hematol Oncol. 2014 Dec;12(12 Suppl 19):12-7. Clin Adv Hematol Oncol. 2014. PMID: 25768104 Review. No abstract available.
• Chemotherapy in the treatment of neuroendocrine malignant tumors.

  Rougier P, Mitry E. Rougier P, et al. Digestion. 2000;62 Suppl 1:73-8. doi: 10.1159/000051859. Digestion. 2000. PMID: 10940691 Review.